secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcturus Therapeutics Holdings Inc. (ARCT)
CIK:        0001768224
Form:       8-K
Filed at:   2024-02-23T23:59:59+00:00
Accession:  0001193805-24-000264
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcturus Therapeutics controller resigns effective March 15, 2024; assistant controller promoted
--------------------------------------------------------------------------------

- Keith C. Kummerfeld, SVP of Finance and Corporate Controller, resigns effective March 15, 2024 to pursue another opportunity.
- Joseph Roberts, formerly Assistant Controller, promoted to Controller of the Company.
- Resignation is not due to any disagreement with the Company's operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768224/000119380524000264/0001193805-24-000264-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768224/000119380524000264/e619292_8k-arct.htm
  HTML page:      https://secwatch.observer/filing/0001193805-24-000264

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer